Study to Assess the Tolerability and Efficacy of Anacetrapib (MK-0859) Co-Administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020)

NCT01524289 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

306

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipoproteinemia Type II
Hypercholesterolemia, Familial

Interventions

DRUG: Anacetrapib
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC